Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK targets a new indication for Nucala, flags PhIII success for a rare disease
GSK targets a new indication for Nucala, flags PhIII success for a rare disease
GSK targets a new indication for Nucala, flags PhIII success for a rare disease
Submitted by
admin
on November 23, 2016 - 10:24am
Source:
Endpoints
News Tags:
Nucala
GSK
EGPA
Headline:
GSK targets a new indication for Nucala, flags PhIII success for a rare disease
Do Not Allow Advertisers to Use My Personal information
